Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Infliximab (Remicade) for Patients With Acute Kawasaki Disease Who Fail to Become Afebrile After Intravenous Gamma Globulin Therapy

NCT00271570 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT00271570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00271570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Infliximab (Remicade) for Patients With Acute Kawasaki Disease Who Fail to Become Afebrile After Intravenous Gamma Globulin Therapy
Lead sponsor
University of California, San Diego
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2004
Completion date
October 31, 2006
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kawasaki disease